백호탕 추출물의 지방장벽 손상 개선을 통한 상피 내 Th2 분화 조절 효과
The Effects of Baekho-tang Extracts on Regulating Th2 Differentiation through Improving Skin Fat Barrier Damage
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives The purpose of this study is to confirm the regulate effect of T helper (Th) 2 differentiation that Baekho-tang extract may produce to improves skin lipid barrier damages. Methods Four-weeks-old NC/Nga mice were divided into four groups: control group (Ctrl, n=10), lipid barrier eliminated group (LBE, n=10), Dexamethasone treatment after lipid barrier elimination group (DxT, n=10), and Baekho-tang extract treatment group after lipid barrier elimination group (BHTT, n=10). Baeko-tang extract was administered for 3 days after removal of the skin fat barrier in BHTT group. Then, we identified changes in external symptoms of the skin, factors affecting skin barrier such as potential of hydrogen (pH), filaggrin (FLG), transepidermal water loss (TEWL) and Th2 differentiation factors like Interleukin (IL)-4, Kallikrein Related Peptidase 7 (KLK7) and protease activated receptor 2 (PAR-2) through our immunohistochemistry. Results After lipid barrier elimination, the reduction of morphological skin inflammations was less in BHTT group than in LBE group and DxT group. Also, pH and TEWL were significantly decreased with BHTT group. However, FLG was significantly increased in BHTT group compared to LBE, DxT, and Ctrl group. All kinds of Th2 differentiation factors (IL-4, KLK7 and PAR-2) were also decreased in BHTT compared to the LBE and DxT. Conclusions As a result of this study, BHT administration decreased pH, TEWL, and increased FLG, thus participating in recovering damaged skin barrier. Since Th2 differentiation factors were decreased as well, BHT’s regulatory effect in sequential immune reactions may be a possible explanation of how it enhances recovery of the damaged lipid barrier.
Abstract
Objectives The purpose of this study is to confirm the regulate effect of T helper (Th) 2 differentiation that Baekho-tang extract may produce to improves skin lipid barrier damages. Methods Four-weeks-old NC/Nga mice were divided into four groups: control group (Ctrl, n=10), lipid barrier eliminated group (LBE, n=10), Dexamethasone treatment after lipid barrier elimination group (DxT, n=10), and Baekho-tang extract treatment group after lipid barrier elimination group (BHTT, n=10). Baeko-tang extract was administered for 3 days after removal of the skin fat barrier in BHTT group. Then, we identified changes in external symptoms of the skin, factors affecting skin barrier such as potential of hydrogen (pH), filaggrin (FLG), transepidermal water loss (TEWL) and Th2 differentiation factors like Interleukin (IL)-4, Kallikrein Related Peptidase 7 (KLK7) and protease activated receptor 2 (PAR-2) through our immunohistochemistry. Results After lipid barrier elimination, the reduction of morphological skin inflammations was less in BHTT group than in LBE group and DxT group. Also, pH and TEWL were significantly decreased with BHTT group. However, FLG was significantly increased in BHTT group compared to LBE, DxT, and Ctrl group. All kinds of Th2 differentiation factors (IL-4, KLK7 and PAR-2) were also decreased in BHTT compared to the LBE and DxT. Conclusions As a result of this study, BHT administration decreased pH, TEWL, and increased FLG, thus participating in recovering damaged skin barrier. Since Th2 differentiation factors were decreased as well, BHT’s regulatory effect in sequential immune reactions may be a possible explanation of how it enhances recovery of the damaged lipid barrier.
참고문헌 (34)
- 김현정, "아토피피부염과 피부 장벽 이상", Allergy Asthma & Respiratory Disease, 1(1), pp.20~28 (2013), 대한 소아알레르기 호흡기학회
- Kubo A, "Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases", J Clin Invest, 122(2), pp.440~447 (2012)
- Rawlings AV, "Moisturization and skin barrier function", Dermatol Ther, 17(1), pp.43~48 (2004)
- Rippke F, "Stratum corneum pH in atopic dermatitis : impact on skin barrier function and colonization with Staphylococcus Aureus", Am J Clin Dermatol, 5, pp.217~223 (2004)
- Silverberg NB, "Inside out or outside in : does atopic dermatitis disrupt barrier function or does disruption of barrier function trigger atopic dermatitis", Cutis, 96(6), pp.359~361 (2015)
- Yang G, "Skin barrier abnormalities and immune dysfunction in atopic dermatitis", Int J Mol Sci, 21(8), pp.2867~ (2020)
- Egawa G, "Multifactorial skin barrier deficiency and atopic dermatitis : Essential topics to prevent the atopic march", J Allergy Clin Immunol, 138(2), pp.350~358 (2016)
- Drislane C, "The role of filaggrin in atopic dermatitis and allergic disease", Ann Allergy Asthma Immunol, 124(1), pp.36~43 (2020)
- Seeliger S, "Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo", FASEB J, 17, pp.1871~1885 (2003)
- Egawa G, "Barrier dysfunction in the skin allergy", Allergol Int, 67(1), pp.3~11 (2018)
- Wu D, "Development and initial validation of a raditional Chinese Medicine symptom-specific outcome measure : a Zheng-related atopic dermatitis symptom questionnaire(ZRADSQ)", Health Qual. Life Outcomes, 11, pp.212~ (2013)
- 임광모, "알레르기성 질환에 대한 한의학적 접근", 동의생리병리학회지, 16(5), pp.1~839 (2002), 한의병리학회
- Seop HM, "Sanghanronjiphae", pp.301~ (2005), Hakwon publisher
- Koh-Woon Kim, "Osteogenic differentiation of human mesenchymal stem cells promoted by the crude extracts of the mixture of Cortex mori radicis, Patrinia saniculaefolia", Molecular & Cellular Toxicology, 11(4), pp.475~482 (2015), 대한독성 유전단백체 학회
- Inoue J, "Suppression of skin lesions by transdermal application of CpG-oligodeoxynucleotides in NC", Nga mice, a model of human atopic dermatitis, 2007, pp.1, 178~
- Lee IS, "The effects of Baekho-tang on 1-Fluoro-2, 4-dinitrofluorobenzeneinduced allergic dermatitis in BALB", c mice, 2016, pp.16, 349~354
- Lin CJ, "Bai-Hu-tang, ancient Chinese medicine formula, may provide a new complementary treatment option for sepsis", Evid Based Complement Alternat Med, 2013, pp.193084~ (2013)
- Brislinger D, "Bai Hu tang, Si Ni Tang, and Xue Bi tang amplify pro-inflammatory activities and reduce apoptosis in endothelial cells in a cell culture model of sepsis", J Ethnopharmacol, 28(225), pp.309~318 (2018)
- Zaniboni MC, "Skin barrier in atopic dermatitis : beyond filaggrin", An Bras Dermatol, 91(4), pp.472~478 (2016)
- Hönzke S, "Influence of Th2 cytokines on the cornified envelope, tight junction proteins, and ß-Defensins in filaggrin-deficient skin equivalents", J Invest Dermatol, 136(3), pp.631~639 (2016)
- Jung AR, "Douchi (fermented Glycine max Merr.)alleviates atopic dermatitis-like skin lesions in NC", Nga mice by regulation of PKC and IL-4, 2016, pp.16(1), 416~
- Kim HJ, "Understanding of skin barrier and integrated treatment on atopic dermatitis", Journal Skin Barrier Research, 12(1), pp.67~78 (2010)
- Scharschmidt TC, "Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens", J Allergy Clin Immunol, 124, pp.496~506 (2009)
- Demerjian M, "Acute modulations in permeability barrier function regulate epidermal cornification : role of caspase-14 and the protease-activated receptor type 2", Am J Pathol, 172(1), pp.86~97 (2008)
- Chen JQ, "Roles of kallikrein-related peptidase in epidermal barrier function and related skin diseases", Int J Dermatol Venereol, 2(3), pp.150~155 (2019)
- Demerjian M, "Acute modulations in permeability barrier function regulate epidermal cornification : role of caspase-14 and the protease-activated receptor type 2", Am J Pathol, 172(1), pp.86~97 (2008)
- Soumelis V, "Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP", Nat Immunol, 3(7), pp.673~680 (2002)
- Hatano Y, "Maintenance of an acidic stratum corneum prevents emergence of murine atopic dermatitis", J Invest Dermatol, 129(7), pp.1824~1835 (2009)
- 임강현, "석고의 생쥐 비장세포 인터루킨-4 분비에 미치는 효과", 대한본초학회지, 17(2), pp.16~144 (2002), 대한본초학회
- 정미림, "Effects of Ethanol Extracts of Anemarrhena asphodeloides on Skin Barrier Function by Inflammation", 한방안이비인후피부과학회지, 31(2), pp.11~23 (2018), 대한한방안이비인후피부과학회[DOI]
- Ju YS, "Ungok herbology", pp.416~422 (2013), Woosuk Press
- Boguniewicz M, "Atopic dermatitis : the updated practice parameter and beyond", Allergy Asthma Proc, 35(6), pp.429~434 (2014)
- Wollenberg A, "Proactive therapy of atopic eczema--an evidence-based concept with a behavioral background", J Dtsch Dermatol Ges, 7(2), pp.117~121 (2009)
- Clark M, "A big data approach to the concordance of the toxicity of pharmaceuticals in animals and humans", Regul Toxicol Pharmacol, 96, pp.94~105 (2018)
